99% Savings - Buy Just @1 Rs X
Symbiva 200 Capsule is a commercial drug that is prescribed in the form of Capsule. It is typically used for the treatment of Asthma. The alternative uses of Symbiva 200 Capsule have also been explained below.
The optimal dosage of Symbiva 200 Capsule is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Symbiva 200 Capsule also has some side effects, the most common being Nasopharyngitis, Headache, Back Pain. Apart from the aforementioned side effects, Symbiva 200 Capsule can also lead to other problems, which have been listed below. Such side effects of Symbiva 200 Capsule normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Symbiva 200 Capsule's effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Symbiva 200 Capsule related warnings talks about Symbiva 200 Capsule's effects on the liver, heart and kidney.
Some other conditions that can be affected by Symbiva 200 Capsule are listed in the contraindications section below.
Drug reaction of Symbiva 200 Capsule with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Symbiva 200 Capsule is safe while driving, and is is addictive in nature.
Symbiva 200 Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Symbiva 200 Capsule safe for pregnant women?
Symbiva may have some side effects during pregnancy. Pregnant women should discontinue the use of Symbiva, and talk to their doctor, if they notice any discomfort.
Is the use of Symbiva 200 Capsule safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Symbiva. Immediately discontinue Symbiva if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Symbiva 200 Capsule on the Kidneys?
Symbiva does not damage the kidneys.
What is the effect of Symbiva 200 Capsule on the Liver?
Symbiva is not harmful for the liver.
What is the effect of Symbiva 200 Capsule on the Heart?
Symbiva may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Symbiva 200 Capsule unless your doctor advises you to do so -
Is this Symbiva 200 Capsule habit forming or addictive?
Symbiva 200 Capsule is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Symbiva 200 Capsule since it will not make you feel sleepy.
Is it safe?
Yes, but consume Symbiva 200 Capsule only on doctor's advice.
Is it able to treat mental disorders?
Symbiva 200 Capsule is unable to treat or cure mental disorders.
Interaction between Food and Symbiva 200 Capsule
Taking Symbiva 200 Capsule with food does not harm your health.
Interaction between Alcohol and Symbiva 200 Capsule
Taking Symbiva 200 Capsule with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca